Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. PharmaCielo Ltd.
  6. Financials
    PCLO   CA71716K1012

PHARMACIELO LTD.

(PCLO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 298289169--
Entreprise Value (EV)1 298289169169169
P/E ratio -8,47x--8,77x-114x7,13x
Yield -----
Capitalization / Revenue 379x109x42,0x6,86x3,58x
EV / Revenue 379x109x42,0x6,86x3,58x
EV / EBITDA -15,2x-12,3x-12,7x73,5x8,87x
Price to Book 6,64x----
Nbr of stocks (in thousands) 97 825138 739148 634--
Reference price (CAD) 3,052,081,141,141,14
Announcement Date 04/29/202005/03/2021---
1 CAD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 -0,792,654,0424,747,4
EBITDA1 -12,4-19,6-23,6-13,42,3119,1
Operating profit (EBIT)1 -32,9-31,8--20,2-7,7119,8
Operating Margin --4 042%--501%-31,2%41,7%
Pre-Tax Profit (EBT) -32,7-----
Net income1 -32,6-34,7-43,8-20,5-1,2826,5
Net margin --4 406%-1 649%-509%-5,20%56,0%
EPS2 -0,41-0,36--0,13-0,010,16
Dividend per Share ------
Announcement Date 04/18/201904/29/202005/03/2021---
1 CAD in Million
2 CAD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 0,880,680,450,521,183,30
EBITDA1 -5,83-3,30-4,53-2,82-1,97-0,29
Operating profit (EBIT)1 ---6,36-5,19-4,35-3,79
Operating Margin ---1 427%-991%-369%-115%
Pre-Tax Profit (EBT) ------
Net income1 -19,9--7,22-3,88-2,90-2,60
Net margin -2 259%--1 621%-741%-246%-78,8%
EPS2 ---0,05-0,02-0,02-0,02
Dividend per Share ------
Announcement Date 05/03/202105/31/202108/20/2021---
1 CAD in Million
2 CAD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow ------
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share -0,46----
Cash Flow per Share -0,16-0,26----
Capex1 5,6510,15,431,421,402,00
Capex / Sales -1 278%205%35,2%5,67%4,22%
Announcement Date 04/18/201904/29/202005/03/2021---
1 CAD in Million
Key data
Capitalization (CAD) 169 443 173
Capitalization (USD) 136 972 477
Net sales (CAD) 2 654 000
Net sales (USD) 2 142 043
Free-Float 97,8%
Free-Float capitalization (CAD) 165 651 687
Free-Float capitalization (USD) 133 907 561
Avg. Exchange 20 sessions (CAD) 113 165
Avg. Exchange 20 sessions (USD) 91 336
Average Daily Capital Traded 0,07%
EPS & Dividend